Prudential Financial’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-373
Closed -$29K – 2665
2022
Q2
$29K Buy
+373
New +$37.4K ﹤0.01% 2622
2019
Q4
– Sell
-144
Closed -$244K – 2440
2019
Q3
$244K Sell
144
-125
-46% -$189K ﹤0.01% 2262
2019
Q2
$432K Buy
+269
New +$533K ﹤0.01% 2134

Other funds holding KRSA

Prudential Financial's KRSA Position: Q3 2022 in Review

Prudential Financial sold out of Korsana Biosciences (KRSA) in Q3 2022, closing a stake of 373 shares — an estimated $29K sold.

Prudential Financial first reported a position in KRSA in Q2 2019 and held it in 3 quarters. The position peaked at $432K in Q2 2019. 34 funds tracked by Wall St. Rank hold KRSA as of Q3 2022.

  • Prudential Financial reported no remaining Korsana Biosciences position as of Q3 2022 after selling out during the quarter.
  • Prudential Financial sold 373 Korsana Biosciences shares in Q3 2022, an estimated $29K.
  • Prudential Financial first reported a position in Korsana Biosciences in Q2 2019 and held it in 3 quarters.
  • Prudential Financial's Korsana Biosciences position peaked at $432K in Q2 2019.
  • 34 funds tracked by Wall St. Rank held Korsana Biosciences as of Q3 2022.

Based on Prudential Financial's 13F filing for Q3 2022, filed 4 Nov 2022.